Core Insights - Altria reported revenue of $5.11 billion for the quarter ended December 2024, reflecting a 1.6% increase year-over-year and a surprise of +1.12% over the Zacks Consensus Estimate of $5.05 billion [1] - The company's EPS for the quarter was $1.29, up from $1.18 in the same quarter last year, surpassing the consensus estimate of $1.27 by +1.57% [1] Revenue Breakdown - Net revenue from Oral tobacco products was $663 million, exceeding the average estimate of $646.04 million, with a year-over-year increase of +2.5% [4] - Revenue from Smokeable Products reached $4.42 billion, slightly above the estimated $4.36 billion, marking a +1.7% change compared to the previous year [4] - Net revenue from All Other/Financial Services was reported at $19 million, which is a significant decline of -29.6% year-over-year, surpassing the average estimate of $17.50 million [4] Operating Income - Operating income for Oral tobacco products was $453 million, slightly above the average estimate of $446.59 million [4] - Adjusted operating income for Smokeable Products was reported at $2.71 billion, just below the estimated $2.72 billion [4] - The operating loss for All Other/Financial Services was -$123 million, worse than the average estimate of -$92 million [4] Stock Performance - Altria's shares have returned +0.7% over the past month, compared to a +1.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
Here's What Key Metrics Tell Us About Altria (MO) Q4 Earnings